Regulatory CD8+ T cells associated with erosion of immune surveillance in persistent virus infection suppress in vitro and have a reversible proliferative defect

Journal of Immunology

Volumn 191, Issue 1, 2013, Pages 312-322

  Hu, Zhuting ^a   Zhang, Weijun ^a   Usherwood, Edward J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; HERPES VIRUS INFECTION; IMMUNOPHENOTYPING; IMMUNOSURVEILLANCE; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; IMMUNE TOLERANCE; IMMUNOLOGIC SURVEILLANCE; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NIH 3T3 CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 84879644705     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201773     Document Type: Article

References (69)

1. Niller, H. H., H. Wolf, and J. Minarovits. 2009. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin. Cancer Biol. 19: 158-164.
2. Cannon, M., and E. Cesarman. 2000. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy. Semin. Oncol. 27: 409-419. (Pubitemid 30626439)
3. Carbone, A., E. Cesarman, M. Spina, A. Gloghini, and T. F. Schulz. 2009. HIV-associated lymphomas and γ-herpesviruses. Blood 113: 1213-1224.
4. Sunil-Chandra, N. P., S. Efstathiou, J. Arno, and A. A. Nash. 1992. Virological and pathological features of mice infected with murine γ-herpesvirus 68. J. Gen. Virol. 73: 2347-2356.
5. Barton, E., P. Mandal, and S. H. Speck. 2011. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu. Rev. Immunol. 29: 351-397.
6. Sunil-Chandra, N. P., S. Efstathiou, and A. A. Nash. 1992. Murine gamma-herpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73: 3275-3279. (Pubitemid 23014183)
7. Weck, K. E., S. S. Kim, I. V. Virgin HW, and S. H. Speck. 1999. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 73: 3273-3283. (Pubitemid 29135720)
8. Flaño, E., S. M. Husain, J. T. Sample, D. L. Woodland, and M. A. Blackman. 2000. Latent murine γ-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165: 1074-1081.
9. Stewart, J. P., E. J. Usherwood, A. Ross, H. Dyson, and T. Nash. 1998. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187: 1941-1951. (Pubitemid 28285564)
10. +) T cell control and morbidity. J. Gen. Virol. 82: 1971-1981.
11. Tibbetts, S. A., L. F. van Dyk, S. H. Speck, and H. W. Virgin, IV. 2002. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J. Virol. 76: 7125-7132. (Pubitemid 41246226)
12. Tsai, C. Y., Z. Hu, W. Zhang, and E. J. Usherwood. 2011. Strain-dependent requirement for IFN-γ for respiratory control and immunotherapy in murine gammaherpesvirus infection. Viral Immunol. 24: 273-280.
13. Ehtisham, S., N. P. Sunil-Chandra, and A. A. Nash. 1993. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67: 5247-5252. (Pubitemid 23241355)
14. + T cells. J. Exp. Med. 184: 863-871.
15. Rouse, B. T., P. P. Sarangi, and S. Suvas. 2006. Regulatory T cells in virus infections. Immunol. Rev. 212: 272-286. (Pubitemid 44116714)
16. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787. (Pubitemid 351707693)
17. Belkaid, Y., and K. Tarbell. 2009. Regulatory T cells in the control of host-microorganism interactions (&z.ast;). Annu. Rev. Immunol. 27: 551-589.
18. + regulatory T cells. Nat. Rev. Immunol. 11: 119-130.
19. + regulatory T cells in persistent human viral infections. Hum. Immunol. 69: 771-775.
20. + Tregs in lupus, autoimmunity, and beyond. Autoimmun. Rev. 9: 560-568.
21. + T cells. J. Immunol. 175: 7093-7097.
22. + T cells as regulatory versus memory T cells. J. Immunol. 185: 803-807.
23. + T cells upon antigen recognition in vitro. J. Immunol. 179: 1039-1048.
24. + regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl. Acad. Sci. USA 104: 8029-8034.
25. Garba, M. L., C. D. Pilcher, A. L. Bingham, J. Eron, and J. A. Frelinger. 2002. HIV antigens can induce TGF-β(1)-producing immunoregulatory CD8+ T cells. J. Immunol. 168: 2247-2254. (Pubitemid 34173033)
26. + T cells. J. Immunol. 178: 3265-3271.
27. + type-1 regulatory T cells. Am. J. Transplant. 7: 1215-1223.
28. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
29. Li, M. O., and R. A. Flavell. 2008. Contextual regulation of inflammation: a duet by transforming growth factor-β and interleukin-10. Immunity 28: 468-476. (Pubitemid 351467045)
30. O'Garra, A., F. J. Barrat, A. G. Castro, A. Vicari, and C. Hawrylowicz. 2008. Strategies for use of IL-10 or its antagonists in human disease. Immunol. Rev. 223: 114-131. (Pubitemid 351986180)
31. Blackburn, S. D., and E. J. Wherry. 2007. IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 15: 143-146. (Pubitemid 46528253)
32. Sun, J., R. Madan, C. L. Karp, and T. J. Braciale. 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15: 277-284.
33. Brockman, M. A., D. S. Kwon, D. P. Tighe, D. F. Pavlik, P. C. Rosato, J. Sela, F. Porichis, S. Le Gall, M. T. Waring, K. Moss, et al. 2009. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virusspecific T cells. Blood 114: 346-356.
34. Clerici, M., T. A. Wynn, J. A. Berzofsky, S. P. Blatt, C. W. Hendrix, A. Sher, R. L. Coffman, and G. M. Shearer. 1994. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93: 768-775. (Pubitemid 24072820)
35. Brady, M. T., A. J. MacDonald, A. G. Rowan, and K. H. Mills. 2003. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur. J. Immunol. 33: 3448-3457. (Pubitemid 37541123)
36. Dolganiuc, A., K. Kodys, A. Kopasz, C. Marshall, T. Do, L. Romics, Jr., P. Mandrekar, M. Zapp, and G. Szabo. 2003. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J. Immunol. 170: 5615-5624. (Pubitemid 36617852)
37. Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. von Herrath. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203: 2461-2472. (Pubitemid 44664616)
38. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309. (Pubitemid 44706933)
39. Molloy, M. J., W. Zhang, and E. J. Usherwood. 2011. Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus. J. Immunol. 186: 6218-6226.
40. Usherwood, E. J., K. A. Ward, M. A. Blackman, J. P. Stewart, and D. L. Woodland. 2001. Latent antigen vaccination in a model gammaherpesvirus infection. J. Virol. 75: 8283-8288. (Pubitemid 32743700)
41. + T-cell help. Eur. J. Immunol. 42: 1080-1088.
42. + T cells in primary and secondary responses. Proc. Natl. Acad. Sci. USA 107: 193-198.
43. Suzuki, H., T. M. Kündig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. Simard, P. S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268: 1472-1476.
44. + T cells: when, where, and how. Annu. Rev. Immunol. 24: 519-540.
45. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
46. Ridge, J. P., F. Di Rosa, and P. Matzinger. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+T-helper and a T-killer cell. Nature 393: 474-478. (Pubitemid 128728267)
47. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-480.
48. Sarawar, S. R., B. J. Lee, S. K. Reiter, and S. P. Schoenberger. 2001. Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus. Proc. Natl. Acad. Sci. USA 98: 6325-6329. (Pubitemid 32488238)
49. Stumhofer, J. S., J. S. Silver, A. Laurence, P. M. Porrett, T. H. Harris, L. A. Turka, M. Ernst, C. J. Saris, J. J. O'Shea, and C. A. Hunter. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8: 1363-1371. (Pubitemid 350131173)
50. Awasthi, A., Y. Carrier, J. P. Peron, E. Bettelli, M. Kamanaka, R. A. Flavell, V. K. Kuchroo, M. Oukka, and H. L. Weiner. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8: 1380-1389. (Pubitemid 350131175)
51. Fitzgerald, D. C., G. X. Zhang, M. El-Behi, Z. Fonseca-Kelly, H. Li, S. Yu, C. J. Saris, B. Gran, B. Ciric, and A. Rostami. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8: 1372-1379. (Pubitemid 350131174)
52. Pflanz, S., J. C. Timans, J. Cheung, R. Rosales, H. Kanzler, J. Gilbert, L. Hibbert, T. Churakova, M. Travis, E. Vaisberg, et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16: 779-790. (Pubitemid 34786477)
53. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569. (Pubitemid 350190247)
54. Leung, H. T., J. Bradshaw, J. S. Cleaveland, and P. S. Linsley. 1995. Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J. Biol. Chem. 270: 25107-25114.
55. + T regulatory cell-mediated suppression. Immunity 30: 636-645.
56. high-induced colitis by a TGF-beta-dependent mechanism. J. Immunol. 170: 2516-2522.
57. - regulatory T cells suppress allergic inflammation. J. Immunol. 187: 6499-6507.
58. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
59. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980.
60. Takeda, I., S. Ine, N. Killeen, L. C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura, and N. Ishii. 2004. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J. Immunol. 172: 3580-3589. (Pubitemid 38337939)
61. Denoeud, J., and M. Moser. 2011. Role of CD27/CD70 pathway of activation in immunity and tolerance. J. Leukoc. Biol. 89: 195-203.
62. +) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice. Proc. Natl. Acad. Sci. USA 95: 15565-15570.
63. Sun, J., H. Dodd, E. K. Moser, R. Sharma, and T. J. Braciale. 2011. CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat. Immunol. 12: 327-334.
64. +) regulatory T cells by continuous antigen stimulation. Eur. J. Immunol. 38: 640-646.
65. Trinchieri, G. 2001. Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection. J. Exp. Med. 194: F53-F57. (Pubitemid 33081514)
66. Josefowicz, S. Z., and A. Rudensky. 2009. Control of regulatory T cell lineage commitment and maintenance. Immunity 30: 616-625.
67. Wan, Y. Y., and R. A. Flavell. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770. (Pubitemid 46279706)
68. Williams, L. M., and A. Y. Rudensky. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8: 277-284. (Pubitemid 46745377)
69. Boyman, O., M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.